edatrexate has been researched along with Breast Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (81.82) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beinart, GA; Booser, D; Broglio, K; Dhingra, K; Frye, D; Gonzalez-Angulo, AM; Gunale, S; Holmes, FA; Hortobagyi, GN; Rosenthal, J; Walters, R; Young, JA | 1 |
| Campbell, DL; Perez, EA; Ryu, JK | 1 |
| Buckman, RA; Eisenhauer, EA; Lopez, P; Muldal, A; Norris, BD; Pritchard, KI; Trudeau, ME; Vandenberg, TA; Verma, SS | 1 |
| Chou, TC; Otter, GM; Sirotnak, FM | 1 |
| Hortobagyi, GN; Ibrahim, N | 1 |
| Jansen, G; Jolivet, J; Kathmann, I; Molthoff, C; Pinard, MF; Ratnam, M; Schornagel, JH; Westerhof, R | 1 |
| Holmes, FA | 2 |
| Baselga, J; D'Andrea, G; Fennelly, D; Gilewski, T; Hudis, C; Moynahan, ME; Norton, L; Raptis, G; Seidman, AD; Sklarin, N; Surbone, A; Templeton, MA; Theodoulou, M; Yao, TJ | 1 |
| Gandara, DR; Kuriakose, P; Perez, EA | 1 |
| de Graeff, A; Dullemond-Westland, A; Schornagel, JH; ten Bokkel Huinink, WW; van Deijk, WA; van der Vegt, S; Verweij, J | 1 |
2 review(s) available for edatrexate and Breast Neoplasms
| Article | Year |
|---|---|
Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Topics: Aminopterin; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Synergism; Drugs, Investigational; Female; Fluorouracil; Genetic Therapy; Humans; Leucovorin; Neoplasm Metastasis; Oncogenes; Paclitaxel; Radiotherapy, Adjuvant | 1996 |
Paclitaxel combination therapy in the treatment of metastatic breast cancer.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Interactions; Drug Synergism; Epirubicin; Fluorouracil; Humans; Ifosfamide; Neoplasm Metastasis; Paclitaxel | 1996 |
5 trial(s) available for edatrexate and Breast Neoplasms
| Article | Year |
|---|---|
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Agranulocytosis; Alopecia; Aminopterin; Anemia; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Female; Humans; Leukopenia; Middle Aged; Nausea; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Breast Neoplasms; Drug Administration Schedule; Female; Folic Acid Antagonists; Humans; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 1993 |
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel; Treatment Outcome | 1999 |
Phase I trial of edatrexate in advanced breast and other cancers.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Infusions, Intravenous; Karnofsky Performance Status; Lung Neoplasms; Maximum Tolerated Dose; Melanoma; Menopause; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome | 2002 |
Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Folic Acid Antagonists; Humans; Middle Aged; Neoplasm Metastasis | 1992 |
4 other study(ies) available for edatrexate and Breast Neoplasms
| Article | Year |
|---|---|
Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.
Topics: Adult; Aminopterin; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Drug Eruptions; Female; Humans; Radiodermatitis | 1995 |
Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.
Topics: Adenocarcinoma; Aminopterin; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Synergism; Humans; Paclitaxel; Prospective Studies; Taxoids; Tumor Cells, Cultured | 1996 |
Paclitaxel-containing combination chemotherapy for metastatic breast cancer.
Topics: Aminopterin; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Mitoxantrone; Paclitaxel; Vinblastine; Vinorelbine | 1996 |
Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Binding Sites; Breast Neoplasms; Carrier Proteins; Cell Membrane; DNA, Complementary; Female; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Humans; Methotrexate; Polymerase Chain Reaction; Quinazolines; Receptors, Cell Surface; RNA, Messenger; Spectrometry, Fluorescence; Structure-Activity Relationship; Tetrahydrofolates; Thiophenes; Tumor Cells, Cultured | 1996 |